tiprankstipranks

Matthew W. Foehr Insider Profile

4 Followers
Matthew W. Foehr, Former Executive Officer at Ligand Pharma, holds 2.91M shares in OmniAb (Ticker: OABI), holds 162.19K shares in Ligand Pharma (Ticker: LGND), holds 0.00 shares in OmniAb, Inc. (Ticker: OABIV). Most recently, Matthew W. Foehr Bought ― shares of OmniAb on Mar 25, 2024 for an estimated value of 1.17M.
tipranks
Matthew W. Foehr

Matthew W. Foehr
Ligand Pharma (LGND)
Former Executive Officer

Ranked #584 out of 97,825 Corporate Insiders

Profitable Transactions

59%
17 out of 29 Profitable Transactions

Average Return

+40.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$35M
42.79%
31.56%
25.49%
0.16%
A breakdown of Matthew W. Foehr's holdings

Insider Roles

OmniAb
(OABI)
President & CEO, Director
Ligand Pharma
(LGND)
Former Executive Officer
Viking Therapeutics
(VKTX)
Director
Qualigen Therapeutics
(QLGN)
Director
Roles that Matthew W. Foehr holds in companies

Most Profitable Insider Trade

Stock:
Viking Therapeutics
(VKTX)
Rating:Informative Buy
Date:May 03, 2022 - May 03, 2023
Return:+754.50%
The most profitable trade made by Matthew W. Foehr

Matthew W. Foehr's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ligand Pharma
Nov 03, 2022
Former Executive Officer
Uninformative Sell
$11.13M
OmniAb
Mar 25, 2024
President & CEO, Director
Informative Buy
1.17M
$15.10M
OABIV
OmniAb, Inc.
Nov 03, 2022
Uninformative Sell
$0.00
Viking Therapeutics
May 03, 2022
Director
Informative Buy
111.15K
$8.99M
Qualigen Therapeutics
Apr 23, 2020
Director
Uninformative Buy
100.00K
$55.59K
List of latest transactions for each holding click on a transaction to see Matthew W. Foehr's performance on stock

Matthew W. Foehr insider profile FAQ

What is the percentage of profitable transactions made by Matthew W. Foehr?
The percentage of profitable transactions made by Matthew W. Foehr is 59%.
    What is the average return per transaction made by Matthew W. Foehr?
    The average return per transaction made by Matthew W. Foehr is 40.10%.
      What stocks does Matthew W. Foehr hold?
      Matthew W. Foehr holds: LGND, OABI, OABIV, VKTX, QLGN stocks.
        What was Matthew W. Foehr’s latest transaction?
        Matthew W. Foehr latest transaction was an Informative Buy of $1.17M.
          What was Matthew W. Foehr's most profitable transaction?
          Matthew W. Foehr’s most profitable transaction was an Informative Buy of VKTX stock on May 3, 2022. The return on the trade was 754.50%.
            What is Matthew W. Foehr's role in Ligand Pharma?
            Matthew W. Foehr's role in Ligand Pharma is Former Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.